How This Evidence Evolved
Microsurgery for Lymphedema
LVA, VLNT, and the emergence of preventive lymphatic microsurgery
Timeline
Early observations and pilot data that first suggested a new direction
Landmark RCTs and pivotal trials that established the evidence base
Mean volume differential reduction at 12 months after lymphovenous bypass: stage 1 or 2 61% vs stage 3 or 4 17% (significantly larger in early stage; overall 42%)
Reduction rate at mean 39.1 months: groin VLNT 40.4% vs physical therapy 8.3% (p=0.02)
Forearm circumference decrease: LVA plus bandaging 4.1 cm (47.3% of preoperative excess) at mean 2.2 years vs bandaging alone 0.8 cm (11.7%) at mean 10.6 months (no p value reported)
Upper limb perimeter after lymph node transplantation (24 women): normal in 10, decreased in 12, unchanged in 2; physiotherapy stopped in 15 (62.5%) (no comparator)
Follow-up studies, subgroup analyses, and real-world validation
Lymphedema at mean 6 months: completed LYMPHA 12.5% (3/24) vs unsuccessful attempt 50% (4/8)
Ipsilateral axillary drainage on ICG lymphography: 67% of 103 upper limbs with BCRL (single-arm study)
Current standard of care and ongoing research directions
Landmark Trials in This Story
Microsurgical lymphovenous anastomosis for treatment of lymphedema: a critical review.
At mean 36.6 months after LVA: improvement in 3 upper and 2 lower extremities; 5 unchanged and 4 progressed (single-arm). Objective proof of clinical efficacy remained lacking.
A prospective analysis of 100 consecutive lymphovenous bypass cases for treatment of extremity lymphedema.
Mean volume differential reduction at 12 months after lymphovenous bypass: stage 1 or 2 61% vs stage 3 or 4 17% (significantly larger in early stage; overall 42%)
Vascularized groin lymph node flap transfer for postmastectomy upper limb lymphedema: flap anatomy, recipient sites, and outcomes
Reduction rate at mean 39.1 months: groin VLNT 40.4% vs physical therapy 8.3% (p=0.02)
Supermicrosurgical lymphaticovenular anastomosis for the treatment of lymphedema in the upper extremities.
Forearm circumference decrease: LVA plus bandaging 4.1 cm (47.3% of preoperative excess) at mean 2.2 years vs bandaging alone 0.8 cm (11.7%) at mean 10.6 months (no p value reported)
Postmastectomy lymphedema: long-term results following microsurgical lymph node transplantation.
Upper limb perimeter after lymph node transplantation (24 women): normal in 10, decreased in 12, unchanged in 2; physiotherapy stopped in 15 (62.5%) (no comparator)
Single Institution Experience with Lymphatic Microsurgical Preventive Healing Approach (LYMPHA) for the Primary Prevention of Lymphedema
Lymphedema at mean 6 months: completed LYMPHA 12.5% (3/24) vs unsuccessful attempt 50% (4/8)
A new indocyanine green fluorescence lymphography protocol for identification of the lymphatic drainage pathway for patients with breast cancer-related lymphoedema
Ipsilateral axillary drainage on ICG lymphography: 67% of 103 upper limbs with BCRL (single-arm study)
First-in-human robotic supermicrosurgery using a dedicated microsurgical robot for treating breast cancer-related lymphedema: a randomized pilot trial.
Patient outcomes at 1 and 3 months, surgery duration and anastomosis quality; robot-assisted anastomosis duration declined from 33 to 16 minutes. Pilot feasibility report, not proof of broad superiority.
Explore the evidence yourself
Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.